Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Canada (1)
Policy
Neurology/Parkinson's Disease (1)
Pharmaceutical, Biotech, Medical Device Company (0)
Payers (usually governmental or public bodies, reimbursement)
Roles and responsibilities
Clinical study phase I